Orna Therapeutics News and Activities

Orna Therapeutics is one of the...

• TOB Iconic 10,000;
• Unicorn.

Acquisition, funding and merger involving Orna Therapeutics.

• Eli Lilly has announced the acquisition of Orna Therapeutics  (posted on February 11 2026).

View the org chart displaying its 28 main executives

Most searched biographies at Orna Therapeutics

• Joe Bolen, Chief Executive Officer
• Matt Roden, Director
• Paul Perreault, Director

Create your alert
to follow the executive moves at Orna Therapeutics.

Orna Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Orna Therapeutics

• News & Media - Orna Therapeutics
• News & Media - Orna Therapeutics

Social media about Orna Therapeutics

• Orna Therapeutics on Wikipedia, Google News & Yahoo Finance
• Orna Therapeutics on LinkedIn, X (Twitter) & YouTube